Literature DB >> 6298543

Chronic caffeine consumption increases the number of brain adenosine receptors.

J P Boulenger, J Patel, R M Post, A M Parma, P J Marangos.   

Abstract

Caffeine, a potent central stimulant, is known to competitively inhibit the specific binding of both adenosine and benzodiazepine receptor ligands to brain membranes in vitro. In mice receiving a diet containing non-toxic doses of caffeine (200 or 400 mg/kg diet) for periods up to 40 days, a dose-related increase in the number of binding sites for [3H]-CHA and [3H] DPX was observed in whole brain membranes without modifications of the receptors' affinity. Furthermore, a transitory increase in the number of [3H]-DZP binding sites was observed. These preliminary data seem to confirm the involvement of the adenosine receptors in the mode of action of caffeine and may be relevant to the development of both tolerance and dependence to some of the central effects of this compound.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6298543     DOI: 10.1016/0024-3205(83)90119-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  28 in total

Review 1.  Genetics of caffeine consumption and responses to caffeine.

Authors:  Amy Yang; Abraham A Palmer; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2010-06-09       Impact factor: 4.530

2.  Quantitative autoradiography of adenosine receptors in brains of chronic naltrexone-treated mice.

Authors:  Alexis Bailey; Rachel M Hawkins; Susanna M O Hourani; Ian Kitchen
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 3.  Caffeine use in children: what we know, what we have left to learn, and why we should worry.

Authors:  Jennifer L Temple
Journal:  Neurosci Biobehav Rev       Date:  2009-01-20       Impact factor: 8.989

4.  Chronic effects of xanthines on levels of central receptors in mice.

Authors:  D Shi; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

5.  Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels.

Authors:  William R Lovallo; Thomas L Whitsett; Mustafa al'Absi; Bong Hee Sung; Andrea S Vincent; Michael F Wilson
Journal:  Psychosom Med       Date:  2005 Sep-Oct       Impact factor: 4.312

6.  Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease.

Authors:  Angelo Fabio Gigante; Artor Niccoli Asabella; Giovanni Iliceto; Tommaso Martino; Cristina Ferrari; Giovanni Defazio; Giuseppe Rubini
Journal:  Neurol Sci       Date:  2018-01-23       Impact factor: 3.307

7.  Caffeine-induced behavioural stimulation is dose- and concentration-dependent.

Authors:  G B Kaplan; N T Tai; D J Greenblatt; R I Shader
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

8.  Effects of caffeine on hippocampal pyramidal cells in vitro.

Authors:  R W Greene; H L Haas; A Hermann
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

Review 9.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

Review 10.  Caffeine physical dependence: a review of human and laboratory animal studies.

Authors:  R R Griffiths; P P Woodson
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.